Atai Beckley (ATAI) EBIT Margin (2021 - 2025)
Atai Beckley's EBIT Margin was -3796.53% in Q3 2025, up 52708.47 percentage points from -56505.00% a year earlier but down 281.51 percentage points from the prior quarter.
Powered by 
Analysis
Atai Beckley (ATAI) EBIT Margin (2021 - 2025) Analysis & Trends
On a trailing twelve-month basis, Atai Beckley's EBIT Margin was -3457.39% through Sep 30, 2025, up 28559.83 percentage points year-over-year; for FY2024, it came in at -33341.23%, up 6617.68 percentage points from FY2023.
- EBIT Margin shows a three-year change of -32674.74 percentage points (FY2021 to FY2024).
- In earlier years, EBIT Margin was -39958.92% in FY2023 (+22181.43 pp), -62140.34% in FY2022 (-61473.85 pp) and -666.49% in FY2021.
- Quarterly EBIT Margin has moved between -186450.00% (Q4 2023) and 20.37% (Q1 2021) over five years.
- Compared with a year earlier, EBIT Margin was higher in three of the last five quarters, with an average year-over-year change of -9107.64 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q3 2023 (a gain of 129252.16 percentage points); the worst was Q3 2022 (a drop of 147554.10 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 37.40% |
| 10 | Atai Beckley | 1.77 Bn | 1.77 Bn | - | -3,796.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -3,796.53% |
| Jun 30, 2025 | -3,515.02% |
| Mar 31, 2025 | -1,309.97% |
| Sep 30, 2024 | -56,505.00% |
| Jun 30, 2024 | -9,424.54% |
| Dec 31, 2023 | -186,450.00% |
| Sep 30, 2023 | -30,843.68% |
| Jun 30, 2023 | -18,524.42% |
| Mar 31, 2023 | -89,767.57% |
| Dec 31, 2022 | -98,855.26% |
| Sep 30, 2022 | -160,095.83% |
| Jun 30, 2022 | -20,798.24% |
| Dec 31, 2021 | -19,641.30% |
| Sep 30, 2021 | -12,541.73% |
| Mar 31, 2021 | 20.37% |
API Access
Atai Beckley EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ATAI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ATAI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ATAI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();